百晓学者学者目录

李青山

副教授、硕士生导师，西安工程大学

精选作品

期刊论文

2026

基于人工智能的大学生诚信问题与思政教育对策分析

李青山，白雪

《大学》

2026

Abstract CT299: Dirozalkib versus crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): Results from the multicenter, randomized, open-label phase 3 trial

Ying Liu, Xiang-Jiao Meng, Yan Yu, Jian-Hua Chen, Run-Xiang Yang, Laiyu Liu, Yan-Qiu Zhao, Rui-Fen Tian, Dian-Ming Li, Rui-Ling Ning, Qingshan Li, Guo-Wu Wu, Li Wang, Xianghui Duan, Xuejie Guo, Yan Hu, Wei-Li Liu, Haifeng Liu

Cancer Research

DOI

2026

Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial.

Hua Zhong, Jing Wang, Run-Xiang Yang, Yongzhong Luo, Wei Zuo, Wei Zhang, Chao Xie, Qingshan Li, Qiang Liu, Xing-Xiang Xu, Qi-Ming Wang, Yan Yu, Yong-Xing Chen, T. Yi, Xu-Hong Min, Jin-Sheng Shi, Jian Yang, Hong Sun, Hua-Lin Chen, Huaqiu Shi, Jun-Zhen Gao, Jian-Hua Shi, Bo Zhang, T. Chu, Kai Li, Bao-Hui Han

The Lancet Oncology

DOI

2026

Hyperthermia sensitizes cervical cancer to chemoradiotherapy by downregulating c-Myc/WSB1/β-catenin expression.

Lu Bai, Feng Li, Sha-Sha Liu, F. Shi, Peng-Hua Cui, Ji-Yuan Yang, Qingshan Li, Ming Liu

International Journal of Hyperthermia

DOI

2026

Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non–Small Cell Lung Cancer

Mark A Socinski, R. Stahel, Dae Ho Lee, F. Cappuzzo, M. Nishio, C. Lovly, O. Ozyilkan, Qingshan Li, Melissa L. Johnson, E. Garon, S. Kılıçkap, F. A. Ferreira da Silva, J. Alatorre-alexander, R. Meng, R. Amin, C. Matheny, S. Troutman, Xiaohui Wen, N. Patil, Wei Zou, D. Rodríguez-Abreu

JAMA Oncology

DOI

2026

Efficacy and safety of mixed formulation aprepitant and palonosetron (QLM2010) for prevention of cisplatin-based highly emetogenic chemotherapy-induced nausea and vomiting: A multicenter, randomized, double-blind, double-dummy, positive-controlled phase III study.

Jie-Er Ying, Qingshan Li, Shuang Leng, Na Li, Chunling Liu, Lin Lai, T. Yi, Kai-Jian Lei, Xisheng Fang, Song-Nan Zhang, Hailong Wei, Honglin Hu, Qiong Wang, Yanxia Zhang, Xingli Gu, Yue Wang, Xiaojie Du, Yuan-Yuan Li, Xiangdong Cheng

Journal of Clinical Oncology

DOI

2026

A double-blind, double-dummy, randomized, controlled phase 3 trial of iparomlimab and tuvonralimab (QL1706) vs QL1604 as consolidation therapy following concurrent or sequential chemoradiotherapy (cCRT/sCRT) in patients (pts) with limited-stage small-cell lung cancer (LS-SCLC).

Lin-Lin Wang, Chunling Liu, Fang-Ling Ning, Hong-Xu Liu, Jiu-Wei Cui, Wen-Zhong Su, Xiang Song, Yan-Yang Wang, Qingshan Li, Changhua Yu, Xianping Cheng, X. Dang, Fu-Rong Hao, Tao Wei, Yang Wei, Hua-Yuan Wang, Jie Wang, X. Qiu, Xiaoyan Kang, Jin-Ming Yu

Journal of Clinical Oncology

DOI

2026

Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial

Zhi Peng, Yan-Qiao Zhang, Hui-Ting Xu, Yan Yang, Mudan Yang, Mingjun Zhang, Ying Cheng, Xiao-Bing Chen, Yue-Yin Pan, Feng Wang, Qingshan Li, Nong Xu, Li-Kun Liu, Kang-Sheng Gu, Juxiang Xiao, Ruixing Zhang, Qun Zhao, Jian Chen, Li-Zhu Lin, Yi-Gui Chen, Yan-Hong Deng, Shi-Rong Cai, BinYao Bai, Yi-Ru Wang, Lin Shen

British medical journal

DOI

2026

A randomized, open-label, parallel-controlled phase 3 trial of benmelstobart plus chemotherapy and anlotinib for first-line treatment of advanced non-squamous non–small cell lung cancer.

Yuan-Kai Shi, Xiao-Yong Tang, Lin Wu, Wei Guo, Yanping Hu, Honghai Wang, Shiguang Xie, Qingshan Li, Yu Yao, Yan Wang

Journal of Clinical Oncology

DOI

2026

Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial

Yang Sun, Hong-Ying Yang, Jing Wang, Hanmei Lou, Dan Li, Ke Wang, Hui Zhang, Tao Wu, Yu-Zhi Li, Chunyan Wang, Gui-Ling Li, Yifeng Wang, Da-Peng Li, Ying Tang, M. Pan, Hong-Yi Cai, Wei-Hu Wang, Bing-Yi Yang, Hua Qian, Qiu-Hong Tian, Desheng Yao, Ying Cheng, Bing Wei, Xiu-Min Li, Tao Wang, Min Hao, Xiaohong Wang, Tie-Jun Wang, Chang Liu, Hong Zhu, Lijing Zhu, Xian-Ling Liu, Yun-Xia Li, Li-Hong Chen, Qingshan Li, Xiaojian Yan, Fei Wang, Hong-Bing Cai, Yun-Yan Zhang, Zhi-Qing Liang, Funan Liu, Yi Huang, B. Xia, Peng-Peng Qu, Genhai Zhu, Youguo Chen, Kun Song, Meili Sun, Zheng-Zheng Chen, Qiang Zhou, Lina Hu, G. Abulizi, Hong-Yan Guo, Si-Hai Liao, Yijing Ye, P. Yan, Q. Tang, Guoping Sun, Ting Liu, Dongmei Lu, Mingxiu Hu, Z. Wang, Bai-Yong Li, Michelle Y. Xia, Xiao-Hua Wu

Nature Communications

DOI

2025

Efficacy and safety of bevacizumab biosimilar SIBP04 compared with bevacizumab (Avastin®) as first-line treatment for locally advanced or metastatic non-squamous non-small-cell lung cancer: A randomized, double-blind, phase 3 trial

Yuan-Kai Shi, Minghong Bi, Qingshan Li, Guolei Wang, Jian-Hua Chen, Ming-Jun Li, Jian-Hua Shi, Jiazhuan Mei, Yinghua Ji, Q. Xia, Yuanqing Feng, Shufeng Xu, Tongmei Zhang, Xiao-Hui Gao, Shubin Tang, Jie Weng, Zhuo Cao, Hongbo Wu, Xiu-Bao Ren, Hua Xie, Hua Liu, Qiang Liu, X. Yin, Xiao-Yong Luo, Jun Chen, Haiming Zhang, Zhiyuan Guo, Cuiming Ding, Xin Jin, Rongli Sun, Sheng Yang

Cancer Pathogenesis and Therapy

DOI

2025

Hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in advanced solid tumors: A multicenter, randomized, double-blind, placebo-controlled phase III trial

S. Qin, Yan-Qiao Zhang, Hong-Li Li, Yong Mao, Wen-Hui Yang, Zhong Xie, Yan-Yan Liu, Lixin Wan, Yanjun Zhang, Xi-Zhi Zhang, Xinghua Han, Li-Zhu Lin, Jun Yao, Yong Li, Yunxiang Wu, Lin Liu, Ming-Jun Zhang, Guixiang Weng, Junyan Yu, Tao Si, Li Zhang, Zhen-Yin Liu, Guoping Zhang, Yong Li, Jin Xia, Xiao-Li Liao, Qingshan Li, Jin Lu, T. Yi, Na Li, Zhitu Zhu, Xiao-Yan Lin, Kai-Jian Lei, Jie Ma, Donglu Zhao, Junye Xiong, Runzi Li, Xiang Lin, Qian Tang, Jun Ma

Blood

DOI

2025

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

Donglu Zhao, Hui-Qiang Huang, Zhi-Ming Li, Li-Hong Liu, Quan-De Lin, Jun Fang, Kai-Yang Ding, Jie Jin, Yanhong Tong, Dengju Li, Zeng-Jun Li, Li-Ping Su, Liang Wang, Wen-Bin Qian, Xiu-Hua Sun, Xiao-Bo Wang, P. He, Wei Yang, Jin-Hai Ren, Li-Ling Zhang, Zun-Min Zhu, L. Qiu, D. Zou, Wei Liu, Hui Zhou, D. Luo, Xiao-Jing Yan, Zhen-Qian Huang, Lin-Tao Bi, Rong Fu, Yun-Hong Huang, Aichun Liu, Xi Zhang, Yao Liu, Hao Zhang, Guangxun Gao, Liangquan Geng, Jing-Bo Wang, Jia Li, Yi Wang, Li-Qun Zou, Ming Jiang, Jian Ge, Xiu-Li Sun, Yan-Li Yang, Hong-Mei Jing, Kai Hu, Zhimin Yan, Shuang-Nian Xu, Xiang-Xiang Zhou, Ganggang Wang, Zhilin Gao, Li Liang, Hong-Feng Ge, Qingshan Li, Zhixue Zhang, Wu-Ping Li, Xiao-Jin Xing, Fengzi Wang, Dongping Huang, Jun Qian, H. Fan, Chan-Juan Shen, Jun Ma

Blood

DOI

2025

Comparison of efficacy and safety of a proposed biosimilar QL1206 with reference denosumab in patients with bone metastasis from breast cancer: A subgroup analysis of a randomized, double-blinded phase III study.

Ya-Xin Liu, Ruyan Zhang, Xiao-Jia Wang, L. Di, Zhen-Dong Chen, Jing-Fen Wang, Tao Sun, Qingshan Li, Jing Cheng, Qing-Yuan Zhang, Xiu-Wen Wang, Jun-Ye Wang, Kang-Sheng Gu, Shi-Hong Wei, Shuqun Zhang, Xiang-Cai Wang, Ping Sun, Chun-Fang Hao, A. Zang, Yu-Jie Li, Cui-Cui Han, Xiao-Yan Kang, Yan-Ling Li, Hui-Ping Li

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

DOI

2025

Efficacy and safety of cafelkibart (LM-108), an anti-CCR8 monoclonal antibody, in combination with anti-PD-1 therapy in patients with pancreatic cancer: Results from phase 1/2 studies.

J. Gong, Chang Liu, Liang Liu, Jun Yao, Yiping Mou, Jing Dai, Youshan Chen, Xiu-Li Yang, M. Ariyapperuma, Yi-Ping Zhang, Junli Xue, Jermaine Coward, Yun Zhou, Yinghua Ji, Qingshan Li, Ru-Sen Zhao, Zhizhen Zhu, B. Markman, Haoyuan Li, Lin Shen

Journal of Clinical Oncology

DOI

2025

A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors

Mingchuan Zhao, Xi-Chun Hu, Pengpeng Zhuang, Aiping Zeng, Yan Yu, Zhen-Dong Chen, Hong-Mei Sun, Weihua Yang, Lili Sheng, P. Peng, Jing-Fen Wang, T. Yi, Minghong Bi, Huaqiu Shi, Ming-Li Ni, Xiumei Dai, Chang-Lu Hu, Hong-Jie Xu, Dong-Qing Lv, Qingshan Li, Kai-Jian Lei, Xia Yuan, O. Jiang, Xi-Cheng Wang, Baihui Hu, Zhe Hou, Z. Su, Song-Zhen Zheng, Ming Zhou, C. Dou

Journal of Bone Oncology

DOI

2025

First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial

Lin Shen, Yan-Qiao Zhang, Zi-Yu Li, Xiao-Tian Zhang, Xiang-Yu Gao, Bo Liu, Yu-Sheng Wang, Y. Ba, Ning Li, Ruixing Zhang, Jing-Dong Zhang, Ye Chen, Jian Chen, Mingzhu Huang, Yang Fu, Mu-Lin Liu, Zheng Liu, Jun Zhao, Wei Li, Jia Wei, Changzheng Li, Nong Xu, Zengqing Guo, Bang-Wei Cao, Lian Liu, Peng Nie, Lixin Wan, Li-Li Sheng, Zhen-Yin Liu, Yi-Fu He, Kang-Sheng Gu, Guo-Wu Wu, Weibo Wang, Fu-Jun Zhang, W. Qiu, Jun Guo, Jie-Er Ying, H. Pan, Hui-Ting Xu, Yuan Yuan, Yuan-Song Bai, Zheng-Hua Wang, Jiye Xu, Xuehong Zhao, Hao Liu, Xi-Zhi Zhang, Wenxiang Dai, Hong-Yan Xu, Ming Liu, Lin Xie, Yong Tang, Jianying Jin, X. Qu, Xuefeng Fang, Ming-Wei Huang, Hao Chen, Zhendong Zheng, Ying Wang, Da-Qing Wang, Xiao-Qin Li, Guohua Yu, Hai-Yan Liu, Yong-Jian Zhou, Dian-Sheng Zhong, Shan Zeng, Mafei Kang, Meiqing Wang, Yong Gao, Wen-Xin Li, Ze-Jun Wang, Minghui Zhang, Jing-Hua Zhang, Qingshan Li, Shujuan Sun, A. Zang, Li-Zhu Lin, Ming Xie, Z. Zhuang, Tao Zhang, Zhifang Yao, Dongmei Lu, Wei Liu, Mingxiu Hu, Z. Wang, Bai-Yong Li, Michelle Y. Xia, Jia-Jia Zhang, Xiang-Ji Ying, D. Pardoll, Jia-Fu Ji

Nature Medicine

DOI

2025

CAMPASS: Benmelstobart in combination with anlotinib vs pembrolizumab in the first-line treatment of advanced non-small cell lung cancer (aNSCLC)—A randomized, single-blind, multicenter phase 3 study.

Bao-Hui Han, Kai Li, Run-Xiang Yang, Yongzhong Luo, Wei Zuo, Chao Xie, Qingshan Li, Xing-Xiang Xu, Qiang Liu, Yan Yu, Qi-Ming Wang, T. Yi, Yong-Xing Chen, Hong Sun, Xu-Hong Min, Huaqiu Shi, Hua-Lin Chen, Jian-Hua Shi, Jin-Sheng Shi, Jun-Zhen Gao

Journal of Clinical Oncology

DOI

2025

Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.

Zheng-Bo Song, Zi-Ming Li, Yi-Ping Zhang, Pingli Wang, Li-Yan Jiang, Yan-Qiu Zhao, Jianying Zhou, Xi-Cheng Wang, W. Zhuang, Jian-Hua Shi, Dingzhi Huang, X. Dang, S. Cang, Yi Gong, Shi Jin, Wei-Wei Li, Xiao-Rong Dong, Junping Zhang, Mingfang Zhao, Xiang-Jiao Meng, Xue-Wen Liu, Jian Fang, Ping Wu, Junguo Lu, Liang-Ming Zhang, Jun-Quan Yang, Xiang Wang, Hui Luo, Jiu-Wei Cui, Zhihong Zhang, Jing Wang, Gaofeng Li, Lin Wu, Yan Yu, Yong Fang, Dong-Qing Lv, Weihua Yang, Lingxiang Chen, N. Yang, Kunyan Li, Rui Ma, Mingxi Wang, Huan Zhou, Sheng-Xiang Hu, Qingshan Li, Z. Zhuang, B. Cao, Wei Zhu, Chun-Wei Xu, Wenjia Wang, Ziyong Xiang, Zhe Shi, Yaolin Wang, Ling Zhang, Shun Lu

European Journal of Cancer

DOI

2025

Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial

Yuan-Kai Shi, Jian Fang, Li-Gang Xing, Yu Yao, Jian Zhang, Lian Liu, Yong-Sheng Wang, Chang-Lu Hu, Jian-Ping Xiong, Zhi-Hua Liu, Run-Xiang Yang, Zhen Wang, Enfeng Zhao, Meng-Zhao Wang, Yan-Qiu Zhao, Ke-Jing Tang, Zhi-Hua Li, Zheng-Bo Song, Yongsheng Li, W. Zhuang, Bo Jin, Ying Cheng, Yanping Hu, Yan-Hong Gu, Lin Wu, Rui Ma, Qi-Tao Yu, Yan Yu, Jun Zhao, Hui Zhao, Dong-Qing Lv, Yan-Hong Shang, P. Xing, Jin Zhou, Xing-Ya Li, Zhe Liu, Zhaoxia Dai, Guo-Hao Xia, Xue-Qin Chen, Y. Ba, C. Bai, Qingshan Li, Guang-Yu An, Wei-Guo Hu, Yin-Xiang Wang, A. Wang-Gillam, Yuli Ding, Qiao Li, Z. Rao

Nature Medicine

DOI

2025

Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors—A phase 1/1b study

Yu-Xiang Ma, Shaoyan Lin, Qun Chen, Jinhui Xue, Yun-Peng Yang, A. Zang, Ying Cheng, Yi-Ping Zhang, Xiang-Cai Wang, Zhen-Dong Chen, Song Qu, Jian-Bo He, Chuan-Ben Chen, Chuan Jin, Dong-Yuan Zhu, Qingshan Li, Xian-Ling Liu, Wu-Yun Su, Y. Ba, Wei-Wei Li, Qian Li, Chang-Bin Zhu, Zhan Huang, Xiao-Qiang Kang, Shilin Xue, Hui Li, Chao Wang, F. Luo, Yan Huang, Li Zhang, Hong-Yun Zhao

Cell Reports Medicine

DOI

2024

Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China.

Xiao-Hua Wu, Yang Sun, Hong-Ying Yang, Jing Wang, Hanmei Lou, Dan Li, Ke Wang, Hui Zhang, Tao Wu, Yu-Zhi Li, Chunyan Wang, Guiling Li, Yifeng Wang, Da-Peng Li, Ying Tang, M. Pan, Hong-Yi Cai, Weihu Wang, Bing Yang, Hua Qian, Qiu-Hong Tian, D. Yao, Ying Cheng, Bing Wei, Xiu-Min Li, Tao Wang, Min Hao, Xiaohong Wang, Tie-Jun Wang, J. Ran, Hong Zhu, Lijing Zhu, Xian-Ling Liu, Yun-Xia Li, Li-Hong Chen, Qingshan Li, Xiao-feng yan, Fei Wang, Hong-Bing Cai, Yun-Yan Zhang, Zhiqing Liang, Funan Liu, Yi Huang, B. Xia, Pengpeng Qu, Genhai Zhu, You-Guo Chen, Kun Song, Mei-Li Sun, Zheng-Zheng Chen, Qiang Zhou, Lina Hu, G. Abulizi, Hong Guo, Si-Hai Liao, Yijing Ye, Ping Yan, Qiu Tang, Guo-Ping Sun, Ting Liu, Dongmei Lu, Mingxiu Hu, Z. Wang, Bai-Yong Li, Michelle Y. Xia

The Lancet

DOI

2024

A phase 2/3 study of romiplostim N01 in chemotherapy-induced thrombocytopenia (CIT).

Xiaoxiao Ge, Qing-Yuan Zhang, Haoran Zhang, Zhao-Hong Chen, Shuang Leng, Zhen Wang, Jin-Sheng Shi, Xiao-Qin Li, Zhan-Yu Pan, Qingshan Li, Ming-Jun Zhang, M. Wen, Peng Wang, Zhanxiong Luo, Ying Han, Yu-Jie Li, Xianlin Duan, Xiaoyan Kang, Jing-De Chen, Jin Li

JCO Oncology Practice

DOI

2024

Abstract CT246: Open-label, single-arm, multicenter, phase 2 trial of garsorasib in KRAS G12C-mutated non-small-cell lung cancer

Zi-Ming Li, X. Dang, Ding-Zhi Huang, Shi Jin, Wei-Wei Li, Jian-Hua Shi, Xicheng Wang, Yi-Ping Zhang, Zheng-Bo Song, Junping Zhang, W. Zhuang, Xue-Wen Liu, Li-Yan Jiang, Xiang-Jiao Meng, Mingfang Zhao, Jianying Zhou, Liang-Ming Zhang, Ping-Li Wang, Hui Luo, Jun-Quan Yang, S. Cang, Xiang Wang, Jing Wang, Jiu-Wei Cui, Yan Yu, Zhihong Zhang, Junguo Lu, Weihua Yang, Gaofeng Li, Ji-Feng Feng, D. Lv, Lin Wu, Yong Fang, Yan Wang, Yan-Qiu Zhao, B. Cao, Wei Zhu, Z. Zhuang, Qingshan Li, Mingxi Wang, Huan Zhou, Xiao-Rong Dong, Sheng-Xiang Hu, Jian Fang, Yi-Hong Zhang, Wenjia Wang, Ziyong Xiang, Zhe Shi, Ling Zhang, Shun Lu

Cancer Research

DOI

2024

A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer

Ze-Fei Jiang, Q. Ouyang, Tao Sun, Qing-Yuan Zhang, Y. Teng, Jiu-Wei Cui, Hai-Bo Wang, Yong-Mei Yin, Xiaojia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jing-Fen Wang, Li-Li Zhang, Jin Yang, Jun Qian, M. Yan, Xinlan Liu, T. Yi, Ying Cheng, Man Li, A. Zang, Shu-Sen Wang, Chuan Wang, Xin-Hong Wu, Jing Cheng, Hui Li, Ying Lin, Cui-Zhi Geng, Kang-Sheng Gu, Chun-Wei Xie, H. Xiong, Xiao-Hong Wu, Jun-lan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, J. Nie, Qiang Liu, Kun Wang, Xueli Mo, Li-Lin Chen, Yue-Yin Pan, Pei-Fen Fu, He-Long Zhang, D. Pang, Y. Sheng, Yun-Wei Han, Hong-Xia Wang, S. Cang, Xian Luo, Wenbo Yu, Rong Deng, Chao-Hong Yang, Patricia Keegan

Future Oncology

DOI

2024

CircCCND1调节miR-340-5p/TGIF1轴对H446肺癌细胞恶性生物学行为的影响

Yi Dong, Cuimin Zhu, Xin Liu, Ji-Wei Zhao, Qingshan Li

Zhongguo fei ai za zhi = Chinese journal of lung cancer

DOI

2024

Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or metastatic NSCLC: Final overall survival results from a phase 2 trial.

Shun Lu, Yi-Ping Zhang, Guo-Jun Zhang, Jian-Ying Zhou, S. Cang, Ying Cheng, Gang Wu, P. Cao, Dong-Qing Lv, H. Jian, Xiangming Jin, Cheng-Shui Chen, P. Tian, Kai Wang, G. Jiang, Gong-Yan Chen, Qun Chen, Hui Zhao, C. Ding, Ren-Hua Guo, Guo-peng Sun, Bin Wang, Li-Yan Jiang, Zhe Liu, Jian Fang, Jun-Quan Yang, W. Zhuang, Yun-Peng Liu, Jian Zhang, Yue-Yin Pan, Jun Chen, Qi-Tao Yu, Min Zhao, Jiu-Wei Cui, Dian-Ming Li, T. Yi, Zhuang Yu, Yan Yang, Yan Zhang, Xiu-Yi Zhi, Yun-Chao Huang, Rong Wu, Liangan Chen, A. Zang, Le-Jie Cao, Qingshan Li, Xiao-Lin Li, Yongping Song, Dong-Lin Wang, Shu-Cai Zhang, L. Ding, Ling Zhang, Dong-Mei Ji, Zhilin Shen

Lung Cancer

DOI

2024

Abstract PO1-27-01: Comparing the Efficacy and Safety of TQB2440 versus the Reference Pertuzumab for the Treatment of HER2-Positive Early or Locally Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase 3 Trial

Qing-Yuan Zhang, Shu-Sen Wang, NanLi Li, Q. Cheng, Yu Ren, Xuchen Cao, Jianjun Huang, Cai-Gang Liu, Hong-Wei Yang, Limin Wei, Zhangjun Song, Hua-Ge Zhao, Fang-Ling Ning, Xiaojian Wang, De-gao Zou, Xiao-Hua Zeng, J. Hao, Yun-Jiang Liu, Huijuan Wang, J. Nie, Liang Li, Li-Na Liu, T. Sun, Xiao-Bo Hu, Zhen-Hua Zhai, H. Xiong, Yuan-Qi Zhang, E. Zhou, Jing Sun, Zhenhai Cai, Antai Zhang, Shui Wang, Junyang Mo, Q. Su, Xiuheng Qi, Guo-Ren Zhou, Shuqun Zhang, G. Cui, Wei Wang, M. Fan, Xin-Yu Qian, Xin-Hong Wu, Zhi-Hong Wang, Jiuda Zhao, Yong-Hui Luo, Yan-Ming Zhang, Fuguo Tian, Jiye Zhang, Dong-Ning Chai, Qingshan Li

Cancer Research

DOI

2024

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial

Zefei Jiang, Q. Ouyang, T. Sun, Qing-Yuan Zhang, Yuee Teng, Jiu-Wei Cui, Hai-Bo Wang, Yong-Mei Yin, Xiao-Jia Wang, Xin Zhou, Yong-Sheng Wang, Gang Sun, Jing-Fen Wang, Li-Li Zhang, Jin Yang, Jun Qian, M. Yan, Xin-Lan Liu, T. Yi, Ying Cheng, Man Li, A. Zang, Shu-Sen Wang, Chuan Wang, Xin-Hong Wu, Jing Cheng, Hui Li, Ying Lin, C. Geng, Kang-Sheng Gu, Chun-Wei Xie, H. Xiong, Xiao-Hong Wu, Jun-Lan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, J. Nie, Qiang Liu, Kun Wang, Xue-Li Mo, Li-Lin Chen, Yue-Yin Pan, P. Fu, He-Long Zhang, D. Pang, Y. Sheng, Yun-Wei Han, Hong-Xia Wang, S. Cang, Xian Luo, Wenbo Yu, Rong Deng, Chao Yang, Patricia Keegan

Nature Medicine

DOI

2024

First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study

Jin Li, Zhen-Dong Chen, Yuxian Bai, Bo Liu, Qingshan Li, Jing-Dong Zhang, Jun Zhou, T. Deng, Fuyou Zhou, She-Gan Gao, Shu-Jun Yang, F. Ye, Long Chen, Wei Bai, X. Yin, S. Cang, Lianke Liu, Yue-Yin Pan, Hui Luo, Yanxia Ji, Zhen Zhang, Ju-Feng Wang, Quan-Liang Yang, Na Li, Rong Huang, Chenglin Qu, Jing Ni, Bo Wang, Yan Xu, Jin Hu, Qing-long Shi, Jason Yang

Nature Medicine

DOI

2024

Efficacy and safety of LM-108, an anti-CCR8 monoclonal antibody, in combination with an anti-PD-1 antibody in patients with gastric cancer: Results from phase 1/2 studies.

J. Gong, Chang Liu, Jun Yao, Junli Xue, Jing Dai, Yinghua Ji, B. Markman, A. Hiong, Xiu-Li Yang, Ru-Sen Zhao, Yi Zheng, Qingshan Li, Jun Wu, M. Barve, M. Ariyapperuma, G. Richardson, X. Qin, Crystal Qin, Lin Shen

Journal of Clinical Oncology

DOI

2023

Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial

Hui-Ping Li, Yan Huang, Zhen-Dong Chen, Ai-Ping Zeng, He-Long Zhang, Yan Yu, Shi-Hong Wei, Qingshan Li, Xiao-Jia Wang, Xiang-Cai Wang, Xiu-Wen Wang, Run-Xiang Yang, Xiumei Dai, Ming-Hong Bi, T. Sun, Qing-Yuan Zhang, Cui-Cui Han, Yujie Li, Xiaoyan Kang, Ya-Xin Liu, Li Zhang

BioDrugs

DOI

2023

First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors

Yuan-Yuan Zhao, Yu-Xiang Ma, A. Zang, Ying Cheng, Yiping Zhang, Xiang-Cai Wang, Zhen-Dong Chen, Song Qu, Jian-Bo He, Chuanben Chen, Chuan Jin, Dongyuan Zhu, Qingshan Li, Xian-Ling Liu, Wuyun Su, Y. Ba, Yanrong Hao, Jun-Min Chen, Guoping Zhang, Shen-Hong Qu, Yong Li, W. Feng, Mengxiang Yang, Bao-Rui Liu, W. Ouyang, Jin Liang, Zhuang Yu, Xiaoyan Kang, Shi-Lin Xue, Guihong Yang, Wei Yan, Yingying Yang, Zhi Liu, Yu-Feng Peng, Bill Fanslow, X. Huang, Li Zhang, Hong-Yun Zhao

Journal of Hematology & Oncology

DOI

2023

Denosumab biosimilar (LY01011) in the treatment of bone metastases in patients with solid tumors: A multicenter, randomized, double-blind, active comparator-controlled phase 3 study.

Mingchuan Zhao, Xi-Chun Hu, Ai-Ping Zeng, Yan Yu, Huaqiu Shi, Zhen-Dong Chen, Hongmei Sun, Weihua Yang, Li-Li Sheng, Pei-Jian Peng, Jing-Fen Wang, T. Yi, M. Bi, Ming-Li Ni, Xiumei Dai, Chang-Lu Hu, K. Lei, Xia Yuan, Qingshan Li, D. Lv

Journal of Clinical Oncology

DOI

2023

Personalized intrahepatic cholangiocarcinoma prognosis prediction using radiomics: Application and development trend

Pengyu Chen, Zhen-Wei Yang, Haotong Zhang, Guan Huang, Qingshan Li, Peigang Ning, Haibo Yu

Frontiers in Oncology

DOI

2023

Prognosis of resectable colorectal liver metastases after surgery associated with pathological features of primary tumor

Da-Wei Chen, Qingshan Li, Haibo Yu

Frontiers in Oncology

DOI

2022

A multicenter, randomized, double-blind, phase III trial comparing denosumab biosimilar QL1206 and denosumab in patients with bone metastases from solid tumors.

Hui-Ping Li, Yan Huang, Li Zhang, Zhen-Dong Chen, Ai-Ping Zeng, He-Long Zhang, Yan Yu, Shi-Hong Wei, Qingshan Li, Xiao-Jia Wang, Xiang-Cai Wang, Xiu-Wen Wang, Run-Xiang Yang, Xiumei Dai, M. Bi, T. Sun, Qing-Yuan Zhang, Cui-Cui Han, Qianqian Liu, Yujie Li

Journal of Clinical Oncology

DOI

2022

Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing: A Phase 2 Nonrandomized Clinical Trial.

Jia-Chen Xu, Zheng Liu, H. Bai, Guilan Dong, J. Zhong, R. Wan, A. Zang, Xiaoling Li, Qingshan Li, Jun Guo, N. Du, D. Zhong, Yan Huang, Qun Lv, Jinghua Zhang, Yue Zhao, Li-Ming Gao, Lin Li, Chun-yan Zhang, Jun Zhao, Bao-Lan Li, Zhe Liu, Zhen-Lin Yang, D. Ji, Tao Wang, J. Duan, Zhi-Jie Wang, Jie Wang

JAMA Oncology

DOI

2022

High-dose versus standard-dose intensity-modulated radiotherapy with concurrent paclitaxel plus carboplatin for patients with thoracic esophageal squamous cell carcinoma: a randomized, multicenter, open-label, phase 3 superiority trial.

J. You, Shu-Chai Zhu, Jian-Cheng Li, Jie Li, Junyue Shen, Yidian Zhao, Xiao-ming Li, Lin Jia, Qingshan Li, Jun Yang, Yiqun Wu, W. Shen, Haishan Wu, Xue-Qin Wu, Xiao-Min Wang, Ya-Qiong Ren, Jun He, Ping-ping Lin, Guang-ying Zhu, A. Shi

International Journal of Radiation Oncology, Biology, Physics

DOI

2021

Effect of Chemotherapy on Peripheral Blood DC Cells and Related Immune Cytokines in Patients with Non-Small Cell Lung Cancer

Jingjing Zhang, Dianbin Song, Yi Dong, Lu Bai, Dong-Qi Gao, Shenglin Zhang, Yan Guo, Fu-Bo Li, Xiaolei Yu, Qingshan Li

Open Journal of Internal Medicine

DOI

2017

以职业资格认证为牵引,构建工程硕士实践能力培养体系——以电子与通信工程领域为例

姬红兵，李青山，王爽

《研究生教育研究》，No. 1

下载原文

2010

Clinical Observation on Kanglaite Injection Combined with Small-dose of Cisplatin and 5-FU in the Treatment of Advanced Pancreatic Cancer

Qingshan Li, Xu Gao, Lan Liu

Ef fi cacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label Study

Shun Lu, Yi-Ping Zhang, Guojun Zhang, Jianying Zhou, S. Cang, Ying Cheng, Gang Wu, P. Cao, D. Lv, H. Jian, Chengshui Chen, Xiangming Jin, P. Tian, Kai Wang, G. Jiang, Gong-Yan Chen, Qun Chen, Hui Zhao, C. Ding, R. Guo, Guo-peng Sun, Bin Wang, Li-Yan Jiang, Zhe Liu, Jian Fang, Jun-Quan Yang, W. Zhuang, Yun-Peng Liu, Jian Zhang, Yue-Yin Pan, Jun Chen, Qi-Tao Yu, ee, Min Zhao, Jiu-Wei Cui, Dian-Ming Li, T. Yi, Zhuang Yu, Yan Yang, Yan Zhang, X. Zhi, Yun-Chao Huang, Rong Wu, Liang Chen, A. Zang, Le-Jie Cao, Qingshan Li, Xiaolin Li, Tt, Yong Song, Dong-Lin Wang, Shu-Cai Zhang, L. Ding, Ling Zhang, Xiao-Bin Yuan, Lingxiang Yao, Zhilin Shen

此主页由公开资料整理，尚未经学者本人认领。